ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

Japan approves Novavax COVID vaccine, adding fourth option

Jab, different from Pfizer and Moderna's mRNA vaccines, provides 'diversity'

Novavax's vaccine will be Japan's fourth shot approved for preventing coronavirus infections.    © Reuters

TOKYO -- Japan's Ministry of Health, Labor and Welfare on Tuesday officially approved Novavax's coronavirus vaccine, making it the country's fourth vaccine option.

Chief Cabinet Secretary Hirokazu Matsuno said at a regular news conference that the U.S.-based company's shot will provide the country with "some diversity in vaccines."

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more